Registro Completo |
Biblioteca(s): |
Embrapa Agricultura Digital. |
Data corrente: |
15/04/2004 |
Data da última atualização: |
17/01/2020 |
Autoria: |
FERNANDEZ, J. H.; HAYASHI, M. A. F.; CAMARGO, A. C. M.; NESHICH, G. |
Afiliação: |
JORGE H. FERNANDEZ, Instituto Butantan; MIRIAN A. F. HAYASHI, Instituto Butantan; ANTONIO C. M. CAMARGO, Instituto Butantan; GORAN NESHICH, CNPTIA. |
Título: |
Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE. |
Ano de publicação: |
2003 |
Fonte/Imprenta: |
Biochemichal and Biophysical Research Communications, New York, v. 308, n. 2, p. 219-226, Aug. 2003. |
DOI: |
10.1016/S0006-291X(03)01363-9 |
Idioma: |
Inglês |
Conteúdo: |
Angiotensin I-converting enzyme (ACE) is a dipeptidylcarboxypeptidase which converts angiotensin I into the vasopressor peptide angiotensin II and also inactivates the hypotensive peptide bradykinin, playing an important role in blood pressure regulation. The present work describes the molecular modeling of the N-terminal human somatic ACE in complex with the inhibitor lisinopril, identifying the residues involved in the inhibitor-binding pocket. The obtained results identify differences in the lisinopril lysine moiety-binding residues for N- and C-terminals of sACE domains and an important carboxy-terminal proline hydrophobic accommodations mediated by the aromatic ring of Tyr532 and Tyr1128 residues, respectively. The present model will be useful for the development of a new inhibitor family based on the natural BPP peptides and derivatives, or even to improve the binding capacities and the domain specificity of the already known inhibitors. |
Palavras-Chave: |
Angiotensin I-converting enzyme; Bk-potentiating peptides; Homology modeling; Lisinopril; Modelagem molecular; Molecular modeling; Somatic ACE. |
Categoria do assunto: |
X Pesquisa, Tecnologia e Engenharia |
Marc: |
null Download
Esconder MarcMostrar Marc Completo |
Registro original: |
Embrapa Agricultura Digital (CNPTIA) |